Results 91 to 100 of about 284,051 (203)

High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry

, 2018
International audienceBackground and aims: Cardiovascular risk is high in heterozygous familial hypercholesterolemia (HeFH). The objective of this study was to describe recurrent cardiovascular events in selected patients with HeFH attending lipid ...
Varret, Mathilde, Durlach, V., Pradignac, A., Lalau, D., Benlian, P., Hankard, R., Valéro, R., Dulong, S., Moulin, P., Vergès, B., Ziegler, O., Carrié, Alain, Farnier, Michel, Ferrières, Jean, Valero, Rene, Pucheu, Y., Yelnik, C., Cariou, Bertrand, Peretti, Noël, Bruckert, Eric, Saheb, S., Lefort, B., Girardet, P., Boccara, Franck, Gallo, A., Collet, Xavier, Béliard, Sophie, Krempf, Michael, Beliard, S., Lemale, J., Sultan, A., Carreau, V., Ducluzeau, P., Di Filippo, Mathilde, Ferrari, E., Paillard, F., Vimont, Alexandre, Tounian, P., Rabès, Jean Pierre, Boileau, C., Angoulvant, D., Charriere, Sybil   +41 more
core   +2 more sources

Treatment of Familial Hypercholesterolemia

, 2018
Familial hypercholesterolemia is the most prevalent genetic disorder with a autosomal dominant background. Early detection of the condition is important, diagnosing the disease is easily missed in most of the cases until some abnormally early CVD ...
Alharshani, Bushra Farhan M
core  

Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010

, 2014
Background Untreated patients with familial hypercholesterolemia are at increased risk of premature cardiovascular death. The primary aim of this study was to investigate whether this is also the case in the statin era.
Retterstøl, Kjetil, Veierød, Marit B., Mundal, Liv, Leren, Trond P., Iversen, Per Ole, Ose, Leiv, Borgan, Jens‐Kristian, Sarancic, Mirza   +7 more
core   +1 more source

CASCADE GENETIC SCREENING IN DIAGNOSTICS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: CLINICAL CASE

Российский кардиологический журнал, 2017
.
E. V. Shakhtshneider, D. E. Ivanoshchuk, K. V. Makarenkova, P. S. Orlov, O. V. Timoshchenko, S. S. Bazhan, Yu. P. Nikitin, M. I. Voevoda   +7 more
doaj   +1 more source

Phenotypic Variation in Heterozygous Familial Hypercholesterolemia

, 1998
—Familial hypercholesterolemia (FH) is caused by mutations in the LDL receptor (LDLR) gene and is usually associated with hypercholesterolemia, lipid deposition in tissues, and premature coronary artery disease (CAD).
Xi-Ming Sun, Jiri J. Frohlich, Simon N. Pimstone, Michael R. Hayden, Christele du Souich, Anne K. Soutar   +5 more
core   +1 more source

Familial heterozygous hypercholesterolemia: a clinical case

, 2016
Резюме. У статті наведено клінічний випадок сімейної гетерозиготної гіперхолестеринемії з розвитком у пацієнтки гострого інфаркту міокарда з подальшим проведенням аортокоронарного шунтування.
М'якінькова, Людмила Олександрівна, Катеренчук, Іван Петрович, Вакуленко, Костянтин Євгенійович, Katerenchuk, I. P., Shabliy, L. M., Vakulenko, K. Ye., Шаблій, Людмила Миколаївна, Miakinkova, L. O.   +7 more
core  

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

Vascular Health and Risk Management, 2012
Damon A Bell,1–3 Amanda J Hooper,1,2,4 Gerald F Watts,2,3 John R Burnett1–41Department of Core Clinical Pathology and Biochemistry, PathWest Laboratory Medicine, 2School of Medicine and Pharmacology, 3Lipid Disorders Clinic ...
Bell DA, Hooper AJ, Watts GF, Burnett JR
doaj  

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

, 2017
Alberico Luigi Catapano,1,2 Angela Pirillo,1,2 Giuseppe Danilo Norata1,3,4 1Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 2IRCCS Multimedica Hospital, Sesto San Giovanni, 3Center for the Study of ...
Pirillo A, Norata GD, Catapano AL
core  

Familial hypercholesterolemia: current treatment and advances in management

, 2008
Heterozygous familial hypercholesterolemia is associated with elevated levels of LDL-cholesterol and the development of premature cardiovascular disease. The condition is considerably under-diagnosed and under-treated.
Huijgen, Roeland, Defesche, Joep C., Vissers, Maud N., Lansberg, Peter J., Kastelein, John J. P., Hutten, Barbara A.   +5 more
core   +1 more source